2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · European Heart Journal · 12K citations
https://doi.org/10.1093/eurheartj/ehab368
R
Rudolf A. de Boer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
999
Papers
82.7K
Citations
129
h-index
564
i10-index
Rudolf A. de Boer is an academic researcher from Uppsala University. The author has contributed to research in topics: Heart Failure Treatment and Management & Cardiovascular Function and Risk Factors & Diabetes Treatment and Management. The author has an h-index of 129, co-authored 850 publications.
ORCID: 0000-0002-4775-9140Papers by this author
works2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
2022 · European Heart Journal · 2,435 citations
https://doi.org/10.1093/eurheartj/ehac244
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
2022 · New England Journal of Medicine · 2,390 citations
https://doi.org/10.1056/nejmoa2206286
2023 ESC Guidelines for the management of cardiomyopathies
2023 · European Heart Journal · 2,120 citations
https://doi.org/10.1093/eurheartj/ehad194
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2023 · European Heart Journal · 1,936 citations
https://doi.org/10.1093/eurheartj/ehad195
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
2019 · European Heart Journal · 1,712 citations
https://doi.org/10.1093/eurheartj/ehz641
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat